Hyaluronic Acid-Functionalized Liposomes for Co-delivery of 5-Fluorouracil and Cannabidiol Against Colorectal Cancer
This multifaceted approach presents a promising strategy for CRC therapy, but requires additional optimization and rigorous in vivo investigations to facilitate successful clinical translation. In particular, optimization of drug-release kinetics and thorough in vivo validation are essential to advance this platform toward clinical application.
Authors
- Hamed Hamishehkar (ORCID: https://orcid.org/0000-0001-9905-0662)
- Soheil Abbaspour‐Ravasjani (ORCID: https://orcid.org/0000-0001-7541-1638)
- Mahdi Zeinali (ORCID: https://orcid.org/0000-0003-4641-8982)
- Amin Mahoutforoush (ORCID: https://orcid.org/0000-0002-8399-6725)
- Mehdi Talebi (ORCID: https://orcid.org/0000-0002-3633-2280)
- Leila Asadollahi (ORCID: https://orcid.org/0000-0002-5919-2460)
- Malahat Safavi (ORCID: https://orcid.org/0009-0001-6883-0188)
Institutions
- Khazar University (AZ)
- Zanjan University of Medical Sciences (IR)
- Tabriz University of Medical Sciences (IR)
- University of Tabriz (IR)
Publication Details
- Journal
- Advanced Pharmaceutical Bulletin
- Published
- 2025-10-15
- DOI
- https://doi.org/10.34172/apb.025.43401
- Citations
- 1
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.79